Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$197K Hold
4,100
– – ﹤0.01% 3504
2026
Q2
$215K Buy
+4,100
New +$217K ﹤0.01% 3508
2025
Q1
– Sell
-200,000
Closed -$6.76M – 2240
2024
Q4
$6.76M Buy
+200,000
New +$7.2M 0.01% 850
2022
Q4
– Sell
-11,700
Closed -$344K – 1622
2022
Q3
$344K Buy
11,700
+2,340
+25% +$88.7K ﹤0.01% 1213
2022
Q2
$509K Buy
+9,360
New +$517K ﹤0.01% 1177

Other funds holding GSK

Steven Cohen's GSK Position: Q3 2026 in Review

Steven Cohen sold out of GSK (GSK) in Q3 2026, closing a stake of 2,652,881 shares — an estimated $135M sold.

Steven Cohen first reported a position in GSK in Q4 2015 and held it in 17 quarters. The position peaked at $227M in Q4 2022. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Steven Cohen reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 2,652,881 GSK shares in Q3 2026, an estimated $135M.
  • Steven Cohen first reported a position in GSK in Q4 2015 and held it in 17 quarters.
  • Steven Cohen's GSK position peaked at $227M in Q4 2022.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.